Accès gratuit
Biologie Aujourd'hui
Volume 204, Numéro 4, 2010
Page(s) 301 - 309
Section Les chimiokines : de nouveaux messagers communs entre système nerveux et système immunitaire
Publié en ligne 10 janvier 2011
  • Abbadie C., Chemokines, chemokine receptors and pain. Trends Immunol, 2005, 26, 529–534. [CrossRef] [PubMed] [Google Scholar]
  • Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., DeMartino J.A., MacIntyre D.E., Forrest M.J., Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA, 2003, 100, 7947–7952. [CrossRef] [Google Scholar]
  • Bogen O., Dina O.A., Gear R.W., Levine J.D., Dependence of monocyte chemoattractant protein 1 induced hyperalgesia on the isolectin B4-binding protein versican. Neuroscience, 2009, 159, 780–786. [CrossRef] [PubMed] [Google Scholar]
  • Brodmerkel C.M., Huber R., Covington M., Diamond S., Hall L., Collins R., Leffet L., Gallagher K., Feldman P., Collier P., Stow M., Gu X., Baribaud F., Shin N., Thomas B., Burn T., Hollis G., Yeleswaram S., Solomon K., Friedman S., Wang A., Xue C.B., Newton R.C., Scherle P., Vaddi K., Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. J Immunol, 2005, 175, 5370–5378. [PubMed] [Google Scholar]
  • Costigan M., Moss A., Latrémolière A., Johnston C., Verma-Gandhu M., Herbert T.A., Barrett L., Brenner G.J., Vardeh D., Woolf C.J., Fitzgerald M., T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J Neurosci, 2009, 29, 14415–14422. [CrossRef] [PubMed] [Google Scholar]
  • Cunha T.M., Verri W.A., Jr., Silva J.S., Poole S., Cunha F.Q., Ferreira S.H., A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA, 2005, 102, 1755–1760. [CrossRef] [Google Scholar]
  • Dansereau M.A., Gosselin R.D., Pohl M., Pommier B., Mechighel P., Mauborgne A., Rostène W., Kitabgi P., Beaudet N., Sarret P., Mélik-Parsadaniantz S., Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem, 2008, 106, 757–769. [CrossRef] [PubMed] [Google Scholar]
  • Gao Y.J., Ji R.R., Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther, 2010, 126, 56–68. [CrossRef] [PubMed] [Google Scholar]
  • Gao Y.J., Zhang L., Samad O.A., Suter M.R., Yasuhiko K., Xu Z.Z., Park J.Y., Lind A.L., Ma Q., Ji R.R., JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci, 2009, 29, 4096–4108. [CrossRef] [PubMed] [Google Scholar]
  • Gosselin R.D., Varela C., Banisadr G., Mechighel P., Rostène W., Kitabgi P., Mélik-Parsadaniantz S., Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem, 2005, 95, 1023–1034. [CrossRef] [PubMed] [Google Scholar]
  • Hesselgesser J., Horuk R., Chemokine and chemokine receptor expression in the central nervous system. J Neurovirol, 1999, 5, 13–26. [CrossRef] [PubMed] [Google Scholar]
  • Jung H., Miller R.J., Activation of the nuclear factor of activated T-cells (NFAT) mediates upregulation of CCR2 chemokine receptors in dorsal root ganglion (DRG) neurons : a possible mechanism for activity-dependent transcription in DRG neurons in association with neuropathic pain. Mol Cell Neurosci, 2008, 37, 170–177. [CrossRef] [PubMed] [Google Scholar]
  • Jung H., Toth P.T., White F.A., Miller R.J., Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J Neurochem, 2008, 104, 254–263. [PubMed] [Google Scholar]
  • Jung H., Bhangoo S., Banisadr G., Freitag C., Ren D., White F.A., Miller R.J., Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain. J Neurosci, 2009, 29, 8051–8062. [CrossRef] [PubMed] [Google Scholar]
  • Menetski J., Mistry S., Lu M., Mudgett J.S., Ransohoff R.M., Demartino J.A., Macintyre D.E., Abbadie C., Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses. Neuroscience, 2007, 149, 706–714. [CrossRef] [PubMed] [Google Scholar]
  • Mennicken F., Maki R., de Souza E.B., Quirion R., Chemokines and chemokine receptors in the CNS : a possible role in neuroinflammation and patterning. Trends Pharmacol Sci, 1999, 20, 73–78. [CrossRef] [PubMed] [Google Scholar]
  • Miller R.J., Jung H., Bhangoo S.K., White F.A., Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol, 2009, 417–449. [Google Scholar]
  • Milligan E.D., Zapata V., Chacur M., Schoeniger D., Biedenkapp J., O’Connor K.A., Verge G.M., Chapman G., Green P., Foster A.C., Naeve G.S., Maier S.F., Watkins L.R., Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci, 2004, 20, 2294–2302. [CrossRef] [PubMed] [Google Scholar]
  • Mines M., Ding Y., Fan G.H., The many roles of chemokine receptors in neurodegenerative disorders : emerging new therapeutical strategies. Curr Med Chem, 2007, 14, 2456–2470. [CrossRef] [PubMed] [Google Scholar]
  • Murphy P.M., International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev, 2002, 54, 227–229. [CrossRef] [PubMed] [Google Scholar]
  • Oh S.B., Tran P.B., Gillard S.E., Hurley R.W., Hammond D.L., Miller R.J., Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci, 2001, 21, 5027–5035. [PubMed] [Google Scholar]
  • Perrin F.E., Lacroix S., Aviles-Trigueros M., David S., Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain, 2005, 128, 854–866. [CrossRef] [PubMed] [Google Scholar]
  • Qin X., Wan Y., Wang X., CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons. J Neurosci Res, 2005, 82, 51–62. [CrossRef] [PubMed] [Google Scholar]
  • Ransohoff R.M., Tani M., Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation? Trends Neurosci, 1998, 21, 154–159. [CrossRef] [PubMed] [Google Scholar]
  • Rittner H.L., Brack A., Chemokines and pain. Curr Opin Investig Drugs, 2006, 7, 643–646. [PubMed] [Google Scholar]
  • Rostène W., Kitabgi P., Parsadaniantz S.M., Chemokines : a new class of neuromodulator? Nat Rev Neurosci, 2007, 8, 895–903. [CrossRef] [PubMed] [Google Scholar]
  • Schafers M., Lee D.H., Brors D., Yaksh T.L., Sorkin L.S., Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation. J Neurosci, 2003, 23, 3028–3038. [PubMed] [Google Scholar]
  • Scholz J., Woolf C.J., Can we conquer pain? Nat Neurosci, 2002, 5 Suppl, 1062–1067. [CrossRef] [PubMed] [Google Scholar]
  • Shin N., Baribaud F., Wang K., Yang G., Wynn R., Covington M.B., Feldman P., Gallagher K.B., Leffet L.M., Lo Y.Y., Wang A., Xue C.B., Newton R.C., Scherle P.A., Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2. Biochem Biophys Res Commun, 2009, 387, 251–255. [CrossRef] [PubMed] [Google Scholar]
  • Stoll G., Jander S., Myers R.R., Degeneration and regeneration of the peripheral nervous system : from Augustus Waller’s observations to neuroinflammation. J Peripher Nerv Syst, 2002, 7, 13–27. [CrossRef] [PubMed] [Google Scholar]
  • Sun J.H., Yang B., Donnelly D.F., Ma C., LaMotte R.H., MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia. J Neurophysiol, 2006, 96, 2189–2199. [CrossRef] [PubMed] [Google Scholar]
  • Thacker M.A., Clark A.K., Bishop T., Grist J., Yip P.K., Moon L.D., Thompson S.W., Marchand F., McMahon S.B., CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain, 2009, 13, 263–272. [CrossRef] [PubMed] [Google Scholar]
  • White F.A., Bhangoo S.K., Miller R.J., Chemokines : integrators of pain and inflammation. Nat Rev Drug Discov, 2005a, 4, 834–844. [CrossRef] [PubMed] [Google Scholar]
  • White F.A., Sun J., Waters S.M., Ma C., Ren D., Ripsch M., Steflik J., Cortright D.N., Lamotte R.H., Miller R.J., Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci USA, 2005b, 102, 14092–14097. [CrossRef] [Google Scholar]
  • White F.A., Jung H., Miller R.J., Chemokines and the pathophysiology of neuropathic pain. Proc Natl Acad Sci USA, 2007, 104, 20151–20158. [CrossRef] [Google Scholar]
  • Woolf C.J., Costigan M., Transcriptional and post-translational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci USA, 1999, 96, 7723–7730. [CrossRef] [Google Scholar]
  • Woolf C.J., Salter M.W., Neuronal plasticity : increasing the gain in pain. Science, 2000, 288, 1765–1769. [CrossRef] [PubMed] [Google Scholar]
  • Zhang J., De Koninck Y., Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J Neurochem, 2006, 97, 772–783. [CrossRef] [PubMed] [Google Scholar]
  • Zhang J.M., An J., Cytokines, inflammation, and pain. Int Anesthesiol Clin, 2007, 45, 27–37. [CrossRef] [PubMed] [Google Scholar]
  • Zhang J., Shi X.Q., Echeverry S., Mogil J.S., De Koninck Y., Rivest S., Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci, 2007, 27, 12396–12406. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.